Reducing risk of renal failure in obese patients
Thursday, April 28, 2011 - 16:30
in Health & Medicine
The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).